Medisafe's Impact on Adherence
Medisafe users with hypertension and hyperlipidemia have significantly higher medication persistence than a matched control group.
Medication sitting unused in the cabinet doesn’t do any good – from the forgetful patient, to the pharmacist, to the precribing physician, back to the pharma company that developed it. Medisafe is a complete continuum-of-care solution providing peace of mind to millions of users while helping to solve the $300 billion medication non-adherence problem.

Our approach to solving non-adherence sits squarely in the middle of the Healthcare Triple Aim Triangle.
Patient Experience Medisafe empowers people to take control of their health and provides peace-of-mind through a personalized, interactive experience that saves time, frustration and money.
Population Health Medisafe has logged billions of data points related to adherence that provides detailed insights into disease state, demographics, and more.
Controlling Costs Medisafe helps partners manage risk and improve outcomes with real-time data on patient adherence patterns.
Medisafe users with hypertension and hyperlipidemia have significantly higher medication persistence than a matched control group.
Reduction in systolic blood pressure for Stage 2 hypertensive users
Adherence improvement for users who add a Medisafe caregiver
of Stage 2 hypertensive Medisafe users reduced their risk category to Stage 1 or below
Medisafe delivers high rates of adherence now and beyond the first fill - no matter how complex the dosing. We can prove it.
All our research studiesDavid takes 26 different medications each day to help to manage his epilepsy. This is how he uses Medisafe to stay in control and live his life.
When Makeba’s son was rushed to the ER, doctors raced to find the problem. Diagnosis: Crohn’s Disease. Here’s how this busy mother of 4 stays on top of it all.